Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$1.27M Buy
202,240
+140,460
+227% +$1.54M ﹤0.01% 3353
2014
Q2
$902K Buy
61,780
+36,480
+144% +$556K ﹤0.01% 3649
2014
Q1
$497K Buy
25,300
+13,560
+116% +$282K ﹤0.01% 4247
2013
Q4
$220K Buy
11,740
+660
+6% +$9.07K ﹤0.01% 5192
2013
Q3
$147K Buy
11,080
+6,140
+124% +$77.1K ﹤0.01% 5558
2013
Q2
$44K Buy
+4,940
New +$49K ﹤0.01% 6884

Other funds holding FRO

UBS's FRO Position: Q3 2014 in Review

UBS reduced its Frontline (FRO) stake by 88% in Q3 2014, selling an estimated $208K and leaving 2,718 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #8192.

UBS first reported a position in FRO in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.26M in Q1 2014. 83 funds tracked by Wall St. Rank hold FRO as of Q3 2014.

  • UBS held 2,718 shares of Frontline worth $17K as of Q3 2014.
  • UBS sold 19,038 Frontline shares in Q3 2014, an estimated $208K.
  • Frontline made up ﹤0.01% of UBS's portfolio in Q3 2014, its #8192 holding.
  • UBS first reported a position in Frontline in Q2 2013 and has held it in 6 quarters since.
  • UBS's Frontline position peaked at $1.26M in Q1 2014.
  • 83 funds tracked by Wall St. Rank held Frontline as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.